Rheumatoid arthritis continues to increase in low-middle SDI and low SDI quintiles based on GBD 1990-2021

根据1990-2021年全球疾病负担研究(GBD)数据,类风湿性关节炎在低至中等社会发展指数(SDI)和低SDI五分位人群中的发病率持续上升。

阅读:1

Abstract

INTRODUCTION: Age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), and age-standardized disability-adjusted life years (ASDR) of rheumatoid arthritis (RA) and their trends at the global, regional, and national levels were determined using data from the Global Burden of Disease (GBD) 2021 study. METHODS: The burden of RA was investigated in relation to age, sex, and sociodemographic index (SDI), drawing upon data from the GBD 2021 study. The ASIR, ASPR, and ASDR at the global, regional, and national levels were extracted. The estimated annual percentage change (EAPC) in the ASIR, ASPR, and ASDR was calculated across all levels from 1990 to 2021, supplemented by cluster and frontier analyses. RESULTS: In 2021, there were 17.92 million cases of RA globally, with the ASIR increasing from 10.42 to 11.8 cases per 100,000 individuals (EAPC of 0.49 [95% confidence interval: 0.46–0.52]) between 1990 and 2021. This substantial rise was consistently observed across all age and sex strata, Socio-demographic Index quintiles, and Global Burden of Disease regions. The most pronounced increase was in the low-middle SDI quintile in the ASIR for RA between 1990 and 2021. Among 54 GBD regions, the most significant increase was observed in Andean Latin America and Equatorial Guinea. CONCLUSION: By 2021, the global burden of RA was largely concentrated in the low-middle and low SDI quintiles, especially in Andean Latin America and Northern Africa, with the burden continuing to grow. These findings highlight an urgent need for targeted interventions in underserved regions, including enhanced early diagnosis capabilities and equitable access to disease-modifying therapies to mitigate rising disability burdens. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41927-025-00570-3.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。